Literature DB >> 16891438

Interstitial lung disease: progress and problems.

S J Bourke1.   

Abstract

Interstitial lung disease involves all areas of medicine as it often occurs in patients with comorbidities or as a consequence of systemic diseases and their treatment. Typically the physician is faced with a breathless patient, a diffusely abnormal chest radiograph, and a wide differential diagnosis. Progress has been made in using high resolution computed tomography as the key investigation in characterising the pattern and extent of the disease. Bronchoalveolar lavage is particularly important in excluding infection as a cause of diffuse lung infiltrates. Surgical lung biopsies have led to a new classification system for the range of histopathological patterns of disease that were previously known by the collective term cryptogenic fibrosing alveolitis. Problems persist in deciding when a surgical lung biopsy is clinically justified, in understanding the pathogenesis of these diseases, and in finding more effective treatments.

Entities:  

Mesh:

Year:  2006        PMID: 16891438      PMCID: PMC2585700          DOI: 10.1136/pgmj.2006.046417

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  50 in total

Review 1.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab.

Authors:  Andrew J K Ostor; Adrian J Crisp; Margaret F Somerville; David G I Scott
Journal:  BMJ       Date:  2004-11-27

3.  Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).

Authors:  J Ledingham; C Deighton
Journal:  Rheumatology (Oxford)       Date:  2005-01-05       Impact factor: 7.580

4.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

Authors:  David A Lynch; J David Godwin; Sharon Safrin; Karen M Starko; Phil Hormel; Kevin K Brown; Ganesh Raghu; Talmadge E King; Williamson Z Bradford; David A Schwartz; W Richard Webb
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

5.  Role of high-resolution computed tomography in idiopathic pulmonary fibrosis: the final word?

Authors:  Theresa C McLoud
Journal:  Am J Respir Crit Care Med       Date:  2005-08-15       Impact factor: 21.405

6.  Outcomes and safety of surgical lung biopsy for interstitial lung disease.

Authors:  Christopher J Lettieri; Ganesh R Veerappan; Donald L Helman; Charles R Mulligan; Andrew F Shorr
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

Review 7.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 8.  Clinical advances in the diagnosis and therapy of the interstitial lung diseases.

Authors:  Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

9.  Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias.

Authors:  Y Ohtani; S Saiki; M Kitaichi; Y Usui; N Inase; U Costabel; Y Yoshizawa
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

10.  Central nervous system sarcoidosis--diagnosis and management.

Authors:  J P Zajicek; N J Scolding; O Foster; M Rovaris; J Evanson; I F Moseley; J W Scadding; E J Thompson; V Chamoun; D H Miller; W I McDonald; D Mitchell
Journal:  QJM       Date:  1999-02
View more
  13 in total

1.  Determination of disease phenotypes and pathogenic variants from exome sequence data in the CAGI 4 gene panel challenge.

Authors:  Kunal Kundu; Lipika R Pal; Yizhou Yin; John Moult
Journal:  Hum Mutat       Date:  2017-06-27       Impact factor: 4.878

2.  Computer-aided detection of early interstitial lung diseases using low-dose CT images.

Authors:  Sang Cheol Park; Jun Tan; Xingwei Wang; Dror Lederman; Joseph K Leader; Soo Hyung Kim; Bin Zheng
Journal:  Phys Med Biol       Date:  2011-01-25       Impact factor: 3.609

Review 3.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

4.  Ultrasound in the evaluation of interstitial pneumonia.

Authors:  V Lo Giudice; A Bruni; E Corcioni; B Corcioni
Journal:  J Ultrasound       Date:  2008-02-20

5.  Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases.

Authors:  J Ngo; M Matsuyama; C Kim; I Poventud-Fuentes; A Bates; S L Siedlak; H-G Lee; Y Q Doughman; M Watanabe; A Liner; B Hoit; N Voelkel; S Gerson; P Hasty; S Matsuyama
Journal:  Cell Death Dis       Date:  2015-03-26       Impact factor: 8.469

6.  Grating-based X-ray Dark-field Computed Tomography of Living Mice.

Authors:  A Velroyen; A Yaroshenko; D Hahn; A Fehringer; A Tapfer; M Müller; P B Noël; B Pauwels; A Sasov; A Ö Yildirim; O Eickelberg; K Hellbach; S D Auweter; F G Meinel; M F Reiser; M Bech; F Pfeiffer
Journal:  EBioMedicine       Date:  2015-08-13       Impact factor: 8.143

7.  Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.

Authors:  W M T van den Hombergh; S O Simons; E Teesselink; H K A Knaapen-Hans; F H J van den Hoogen; J Fransen; M C Vonk
Journal:  Clin Rheumatol       Date:  2018-07-10       Impact factor: 2.980

8.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

9.  Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases.

Authors:  Arsen Arakelyan; Lilit Nersisyan; Martin Petrek; Henry Löffler-Wirth; Hans Binder
Journal:  Front Genet       Date:  2016-05-06       Impact factor: 4.599

10.  99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.

Authors:  Mehrzad Bahtouee; Jamshid Saberifard; Hamid Javadi; Iraj Nabipour; Alireza Raeisi; Majid Assadi; Mohammad Eftekhari
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.